Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

NCT00366002 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder (OAB)

Interventions

DRUG: Darifenacin

Sponsor

Novartis

Collaborators

[object Object]